In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Zepbound® (Tirzepatide, Injectable pen) by Eli Lilly has been FDA-approved since 2023 for Chronic weight management. Weight Method offers a separate option for Lodi residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month — same pricing regardless of location.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Lodi is already seeing results
Zepbound in Lodi, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in Lodi from $329/month with virtual consultations and direct-to-door shipping.
Zepbound® by Eli Lilly is the FDA-approved Injectable pen Tirzepatide product, taken Once weekly and approved in 2023 for Chronic weight management. Tirzepatide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Lodi residents: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Hispanic adults in Lodi face disproportionately high rates of obesity and type 2 diabetes — conditions that Tirzepatide therapy is studied for. Weight Method removes barriers that have historically limited access: our platform is fully bilingual, and our compounded Tirzepatide program (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) starts at $329/month with no insurance needed. Everything happens virtually from your Lodi home.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.